Study to Evaluate Effects of INL1 in Patients With Heart Failure and Reduced Ejection Fraction
Clinical trial NCT03875183 · UNKNOWN
Trial details
- NCT number
- NCT03875183
- Sponsor
- Innolife Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-20
- Primary completion
- 2022-12-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.